Osteoarthritis Therapeutics Market
According to Intent Market Research, the Osteoarthritis Therapeutics Market is expected to grow from USD 7.9 billion in 2023 at a CAGR of 6.9% to touch USD 12.6 billion by 2030. The Osteoarthritis Therapeutics Market is dominated by key players such as, Amgen Inc., AbbVie Inc., Eli Lilly and Company, Regeneron Pharmaceuticals, Inc., and Horizon Therapeutics plc